TCL Archive Review Guidelines For Comprehensive Centers Drafted, NCAB To Consider at December Meeting November 24, 1989
TCL Archive Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million January 19, 1979
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
